Cryo-Cell International, Inc.
General ticker "CCEL" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $30.0M (TTM average)
Cryo-Cell International, Inc. follows the US Stock Market performance with the rate: 11.8%.
Estimated limits based on current volatility of 7.8%: low 3.88$, high 4.54$
Factors to consider:
- Total employees count: 76 (-11.6%) as of 2025
- Top business risk factors: Market acceptance, Technology obsolescence, Regulatory and compliance, Cybersecurity threats, Geopolitical risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-11-30 to 2027-11-30
- 2025-11-30 to 2026-11-30 estimated range: [2.87$, 5.76$]
- 2026-11-30 to 2027-11-30 estimated range: [3.03$, 6.00$]
Financial Metrics affecting the CCEL estimates:
- Positive: with PPE of -13.5 at the end of fiscal year the price was low
- Positive: 0.56 < Operating profit margin, % of 1.53
- Positive: 15.29 < Operating cash flow per share per price, % of 16.26
- Negative: Shareholder equity ratio, % of -30.14 <= 7.04
- Negative: 4.56 < Interest expense per share per price, % of 6.13
- Positive: 3.66 < Industry operating cash flow per share per price (median), % of 3.84
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: -7.72 < Return on assets ratio (scaled to [-100,100]) of -3.79
- Negative: 0 < Industry inventory ratio change (median), % of 0
Short-term CCEL quotes
Long-term CCEL plot with estimates
Financial data
| YTD | 2023-11-30 | 2024-11-30 | 2025-11-30 |
|---|---|---|---|
| Operating Revenue | $31.34MM | $31.99MM | $31.57MM |
| Operating Expenses | $43.65MM | $28.51MM | $31.08MM |
| Operating Income | $-12.30MM | $3.48MM | $0.48MM |
| Non-Operating Income | $-1.06MM | $-0.68MM | $-2.82MM |
| Interest Expense | $1.24MM | $1.86MM | $2.07MM |
| R&D Expense | $1.17MM | $1.24MM | $0.38MM |
| Income(Loss) | $-13.36MM | $2.80MM | $-2.34MM |
| Taxes | $-3.84MM | $2.40MM | $0.09MM |
| Net Income(Loss)* | $-9.52MM | $0.40MM | $-2.43MM |
| Stockholders Equity | $-11.03MM | $-13.22MM | $-18.61MM |
| Inventory | $0.77MM | $0.66MM | $0.41MM |
| Assets | $61.22MM | $64.68MM | $61.73MM |
| Operating Cash Flow | $8.92MM | $6.01MM | $5.48MM |
| Capital expenditure | $7.64MM | $3.60MM | $0.23MM |
| Investing Cash Flow | $-8.14MM | $-4.88MM | $-0.98MM |
| Financing Cash Flow | $-2.07MM | $-0.98MM | $-4.75MM |
| Earnings Per Share** | $-1.14 | $0.05 | $-0.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.